Fabrication of Versatile Hollow Metal-Organic Framework Nanoplatforms for Folate-Targeted and Combined Cancer Imaging and Therapy.
Xiaoli ZengBin ChenYibo SongXiaofeng LinShu-Feng ZhouGuowu ZhanPublished in: ACS applied bio materials (2021)
Metal-organic frameworks (MOFs) have received extensive attention in the field of biomedicine, particularly serving as multifunctional theranostic nanoplatforms by integrating chemodrugs, imaging agents, and targeting agents. Herein, we report a facile strategy for the fabrication of a hollow and monodisperse MOF (denoted h MIL-88B(Fe)@ZIF-8) consisting of ZIF-8 nanoparticles loaded on the external shell of hollow MIL-88B(Fe). In particular, the hybrid hollow MOF was constructed by partially etching spindlelike MIL-88B(Fe) nanoparticles with 2-methylimidazole in the presence of zinc ions. The obtained h MIL-88B(Fe)@ZIF-8 was then used as a drug/cargo delivery vehicle for loading doxorubicin (DOX), manganese oxide (MnO x ) nanoparticles, and folic acid (FA), forming a multifunctional nanoplatform (denoted h M@ZMDF). Importantly, the resulting h M@ZMDF exhibited a specific targeting property for the FA receptor-overexpressed cancer cells (MCF-7 and HepG-2 cells) and then it unloaded DOX and Fe 3+ in the tumor microenvironment. Consequently, DOX played dual roles as a chemotherapeutic drug and a fluorescent imaging agent. Also, the released Fe 3+ could mediate the Fenton reaction and intracellularly generate toxic hydroxyl radicals in the presence of high glutathione in cancer cells. In addition, MnO x nanoparticles could participate in magnetic resonance imaging. Therefore, the versatile h M@ZMDF nanoplatforms have great potential for smart cancer therapy.
Keyphrases
- metal organic framework
- cancer therapy
- drug delivery
- magnetic resonance imaging
- high resolution
- wastewater treatment
- computed tomography
- quantum dots
- squamous cell carcinoma
- papillary thyroid
- fluorescence imaging
- stem cells
- gold nanoparticles
- walled carbon nanotubes
- risk assessment
- cell therapy
- drug induced
- climate change
- water soluble
- living cells
- childhood cancer